December 15, 2024 - 01:23

In a troubling development, families are facing significant barriers to essential treatments for children with autism due to strategic access limitations imposed by UnitedHealth. Sharelle Menard, a mother of a young boy named Benji, shares her harrowing experience. At one point, she believed her son would never find his voice. The challenges were overwhelming; she struggled to comfort him during his frequent outbursts, and simple activities like reading together became impossible.
Menard recalls the relentless cycle of frustration and distress, both for her and for Benji, who often screamed in frustration due to his inability to communicate his needs. This situation highlights the broader issue of access to critical therapies that can profoundly affect the development and quality of life for children with autism. As families navigate these obstacles, the urgent need for equitable and comprehensive healthcare access becomes increasingly clear. The emotional toll on parents and children alike underscores the importance of addressing these systemic issues.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...